COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
Liang Hong(Cleveland Clinic Florida), Taojing Li, De-Ming Ji(China National Pharmaceutical Group Corporation (China)), Shuyan Liang, Kai Duan(University Health Network), Jingwei Xufang, Yunkai Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Tao Deng(Chinese Academy of Medical Sciences & Peking Union Medical College), Cesheng Li(China National Pharmaceutical Group Corporation (China)), Jing Liu(Qingdao University), Dongbo Zhou, Xiao Wu(China National Pharmaceutical Group Corporation (China)), Daoxing Fu(China National Pharmaceutical Group Corporation (China)), Jiayou Zhang(Wuhan Institute of Bioengineering), Xuanxuan Nian(Wuhan Institute of Bioengineering), Jia Rui(Guangzhou University of Chinese Medicine), Zhijun Zhou(China National Pharmaceutical Group Corporation (China)), Fei Xia(Wuhan Institute of Bioengineering), Yan Peng(CITIC Group (China)), Yuwei Li(Sun Yat-sen University), Shang Wang(Peking University), Xiang Wang(Chenzhou First People's Hospital), Juan Zhang(Fujian Medical University), Dong Liu(Renmin University of China), Chunyan Li(Xi'an Jiaotong University), Yong Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hang Zhang, Zhu Chen(University of Science and Technology of China), Yan Zeng(Wuhan Institute of Bioengineering), Xuewei Wang(Chinese Academy of Sciences), Min Mao(Panzhihua University), Xinguo Li(Wuhan Institute of Bioengineering), Lu Feng(China National Pharmaceutical Group Corporation (China)), Zejun Wang(Tongji University), Junzheng Wu, Zhixin Qiu(East China University of Technology), Jia Lu(Inner Mongolia Medical University), Yong Hu, Shihe Huang(Wuhan Institute of Bioengineering), Huanhuan Guo(Harbin Medical University), Lianzhen Lin(China National Pharmaceutical Group Corporation (China)), Ran Qiu(Wuhan Institute of Bioengineering), Yaling Ding, Yanlin He(China National Pharmaceutical Group Corporation (China))
Cited by 5
Related Papers
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
|The Lancet|2016|2.7k
A Cross-Sectional Study of the Microeconomic Impact of Cardiovascular Disease Hospitalization in Four Low- and Middle-Income Countries
|PLoS ONE|2011|269
Comparison of nonhuman primates identified the suitable model for COVID-19
|Signal Transduction and Targeted Therapy|2020|239
Gene expression networks underlying retinoic acid–induced differentiation of acute promyelocytic leukemia cells
|Blood|2000|228
Transmission dynamics of COVID-19 in Wuhan, China: effects of lockdown and medical resources
|Nonlinear Dynamics|2020|145